Literature DB >> 20121698

The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus.

Peter Klein Klouwenberg1, Lydia Tan, Wendy Werkman, Grada M van Bleek, Frank Coenjaerts.   

Abstract

Toll-like receptors (TLRs) play a distinct role in battling respiratory syncytial virus (RSV) infections. However, due to a lack of representative animal models and several early controversies, the field is unclear. In this systematic review, we have elucidated conflicting results and outlined important factors that might affect study outcomes. We reviewed studies that used different doses/viral strains, performed virus propagation in different cell lines, or used different mice strains. The following firm conclusions can be drawn: multiple TLRs activate innate immunity upon RSV infection; TLR4 can influence TLR2 expression, suggesting that optimal induction of multiple signaling pathways is required to elicit protective, rather than deleterious innate immune responses following infection; in mice, TLR4, TLR2/-6, and TLR7 have immune-stimulating properties, while TLR3 activation occurs later and appears to downregulate immune responses; in humans, polymorphism studies have demonstrated an important role for TLR4-signaling; and activation of TLR-signaling leads to antiviral cytokine production, such as TNF-a and IFNs. Viral factors may block these pathways, thereby contributing to immune evasion and RSV survival. A better understanding of the complex interplay between TLRs and severe RSV infections might lead to efficient prophylactic and therapeutic treatments, as well as the development of adequate vaccines combined with TLR adjuvants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20121698     DOI: 10.1615/critrevimmunol.v29.i6.40

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  25 in total

1.  The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.

Authors:  Lydia Tan; Frank E J Coenjaerts; Lieselot Houspie; Marco C Viveen; Grada M van Bleek; Emmanuel J H J Wiertz; Darren P Martin; Philippe Lemey
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

2.  Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses.

Authors:  Susan Morris; Michele S Swanson; Andrew Lieberman; Michelle Reed; Zhenyu Yue; Dennis M Lindell; Nicholas W Lukacs
Journal:  J Immunol       Date:  2011-09-12       Impact factor: 5.422

3.  Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective.

Authors:  Nico Marr; Stuart E Turvey; Nathalie Grandvaux
Journal:  Trends Microbiol       Date:  2013-10-09       Impact factor: 17.079

Review 4.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

Review 5.  Role of aging on innate responses to viral infections.

Authors:  Daniel R Goldstein
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-31       Impact factor: 6.053

6.  Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection.

Authors:  Stanislaw J Gabryszewski; Ofir Bachar; Kimberly D Dyer; Caroline M Percopo; Kristin E Killoran; Joseph B Domachowske; Helene F Rosenberg
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

7.  TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus.

Authors:  Renée N Douville; Yuriy Lissitsyn; Aaron F Hirschfeld; Allan B Becker; Anita L Kozyrskyj; Joel Liem; Nathalie Bastien; Yan Li; Rachel E Victor; Mehtab Sekhon; Stuart E Turvey; Kent T HayGlass
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

8.  Association of Toll-like receptor 3 polymorphisms with chronic hepatitis B and hepatitis B-related acute-on-chronic liver failure.

Authors:  Yihui Rong; Haihan Song; Shaoli You; Bing Zhu; Hong Zang; Yi Zhao; Yongli Li; Zhihong Wan; Hongling Liu; Aimin Zhang; Long Xiao; Shaojie Xin
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

9.  A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection.

Authors:  Jonathan M Ciencewicki; Xuting Wang; Jacqui Marzec; M Elina Serra; Douglas A Bell; Fernando P Polack; Steven R Kleeberger
Journal:  FASEB J       Date:  2014-01-13       Impact factor: 5.191

10.  Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.

Authors:  Eun-Ju Ko; Young-Man Kwon; Jong Seok Lee; Hye Suk Hwang; Si-Eun Yoo; Yu-Na Lee; Young-Tae Lee; Min-Chul Kim; Min Kyoung Cho; You Ri Lee; Fu-Shi Quan; Jae-Min Song; Sujin Lee; Martin L Moore; Sang-Moo Kang
Journal:  Nanomedicine       Date:  2014-08-08       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.